drugset / Trial / NCT02802865
Combined Letrozole and Clomid in Women With Infertility and PCOS
RandomizedParallel-groupOpen-labelTreatment
Summary
This study evaluates the addition of clomid to letrozole for the treatment of infertility in women with polycystic ovary syndrome. Half of the participants will receive letrozole and clomid in combination, while the other half will receive letrozole alone.
Timeline
- Start
- 2016-08
- Primary completion
- 2018-05
- Completion
- 2019-02
Outcome
Met primary endpoint
registry analysis (superiority test); Letrozole vs Letrozole + Clomiphene; p = 0.007; Rate ratio 1.80 (95% CI 1.18 to 2.75); Chi-squared, Corrected NCT02802865 ↗
paper Women who received the combination of letrozole and CC had a statistically higher ovulation rate compared with those who received letrozole alone (27 of 35 women [77%] vs. 15 of 35 women [43%]). PMID 30683591 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clomiphene Citrate | Other / unclassified | 50 mg | Oral |
| Subject | Letrozole | Other / unclassified | 2.5 mg | Oral |